Company Financials

Edwards Lifesciences Corporation Financials

United States dollar

business Edwards Lifesciences Corporation Company Profile

Main Stock Listing

NYSE: EW

Market Capitalization $50.10 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 37.09
Forward PE 29.45
Price to Sales TTM $8.44
Price to Book MRQ $4.81
Enterprise to Revenue 7.88
Enterprise to EBITDA 25.94

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 23.25%
Operating Margin 27.37%
Return on Assets TTM 7.72%
Return on Equity TTM 13.49%

Income Statement

Revenue TTM $5,883,800,064
Revenue per Share TTM $10.02
Quarterly Revenue Growth 14.70%
Gross Profit TTM $4,600,399,872
EBITDA $2,042,600,000
Net Income to Common TTM $1,342,200,064
Diluted EPS TTM $2.28
Quarterly Earnings Growth YoY -90.50%

Balance Sheet

Total Cash MRQ $3,841,999,872
Total Cash per Share MRQ $6.62
Total Debt MRQ $
Total Debt to Equity MRQ 6.86
Current Ratio MRQ 4.00
Book Value per Share MRQ $17.57

Cash Flow

Operating Cash Flow TTM $1,016,800,000
Levered Free Cash Flow TTM $524,500,000

EW Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 580,700,000
Float Shares 574,427,364
Avg 10 Volume 2,089,691
Avg 30 Volume None
Shares Short 5,640,466
Short Ratio 1.67
Short % of Shares 1.11%
% Held by Insiders 0.92%
% Held by Institutions 90.10%

Stock Price Summary

Beta 0.97
Fifty Two Week Low $65.94
Fifty Two Week High $87.89
Fifty Two Week Change 13.82%
Day 50 MA $84.05
Day 200 MA $77.94

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2020-06-01